Logo

leukemia

Rarecells Raises $13M in Series A Round to Develop Liquid Biopsy Early Cancer Detection Tests

The company is planning to develop circulating tumor cell assays for prostate cancer and acute myeloid leukemia and to launch them in the US.

Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy

Researchers looked at relapse-related markers over time in pediatric and young adult acute lymphoblastic leukemia patients after CAR T-cell treatment.

Researchers Force Nanopore Sequencing to Go Short-Read for Copy Number Analysis in Cancer
Premium

Using Oxford Nanopore's MinIon to sequence molecules about 500 bp long, researchers were able to detect copy number aberrations in AML.

Invivoscribe Enters Bioinformatics Market, Hires First CIO
Premium

The molecular diagnostics company seeks to automate its customers' pipelines with AI and diversify beyond hematology.

Acute Lymphoblastic Leukemia Risk Linked to Genetically Mediated Increase in Lymphocyte Count

A team led by researchers at the University of Southern California analyzed genetic links between blood cell traits and ALL susceptibility in children.

Jun 29, 2021

Genotyping May Help Avoid Unnecessary Bone Marrow Biopsies in African Americans

May 26, 2021

Acute Lymphoblastic Leukemia Study Explores Role of DNA Methylation in Outcomes, Treatment

Apr 22, 2021

Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic

Apr 16, 2021

Columbia University-led Study Highlights Bionano Optical Genome Mapping Concordance with Cytogenetics

Mar 11, 2021

Whole-Genome Sequencing Could Replace Cytogenetics in Assessing AML, Myelodysplastic Syndromes

Jan 15, 2021

Bionano Genomics Stock Soars on User Presentations, Public Stock Offering, Renewed Nasdaq Compliance

Jan 14, 2021

Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

Jan 6, 2021

TwinStrand Biosciences Explores Error Reduction Sequencing Tech in Various Applications
Premium

Dec 8, 2020

NGS Bests Flow Cytometry for MRD-Based Prediction of ALL Relapse, Survival, ASH Study Suggests
Premium

Nov 24, 2020

Clinicians Face New Intervention Questions as Clonal Hematopoiesis Mutation Data Evolves
Premium

Nov 17, 2020

Cepheid Developing New Target for BCR-ABL Test for Leukemia Patients
Premium

Nov 13, 2020

Clinical Genomics Nabs Medicare Coverage for Colorectal Cancer Test as Novitas Revises LCD

Nov 12, 2020

Bionano Genomics Q3 Revenues Down 33 Percent

Oct 29, 2020

Single-Cell Analysis Elucidates Mutation Patterns in Myeloid Malignancies

Oct 21, 2020

Single-Cell Sequencing Reveals Clonal Diversity Among AML Patients

Sep 18, 2020

MSK Clonal Hematopoiesis Clinic Aims to Drive New Strategies for Cancer Risk Assessment, Prevention
Premium

Aug 17, 2020

Bionano Genomics Expecting Clinical Validation Studies to Drive Platform Adoption
Premium

Aug 14, 2020

Mission Bio Seeks to Increase Drug Trial Collaborations, Improve Gene and Cell Therapy Efficacy
Premium

Aug 10, 2020

Adaptive Biotechnologies Q2 Revenues Fall 5 Percent, Beat Analyst Estimates

Aug 6, 2020

Adaptive Biotechnologies Receives Expanded FDA Clearance for ClonoSeq MRD Assay

Breaking News
The Scan

Omicron's Sewage Path

The New York Times writes that testing sewage is helping public health officials track Omicron.

IBM Sells Part of Watson Health

The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm.

Identifying the Right Whales

The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought.

Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer

In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.